INNOVATION PHARMACEUTICALS INC. Operating Lease, Expense
INNOVATION PHARMACEUTICALS INC. reported Operating Lease, Expense of $26.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-05-14
- INNOVATION PHARMACEUTICALS INC. operating lease, expense for the quarter ending 2020-03-31 was $26.00K.
- INNOVATION PHARMACEUTICALS INC. operating lease, expense for the quarter ending 2019-12-31 was $28.00K.
- INNOVATION PHARMACEUTICALS INC. operating lease, expense for the quarter ending 2019-09-30 was $58.00K, a 3.57% increase year-over-year.
- INNOVATION PHARMACEUTICALS INC. operating lease, expense for the quarter ending 2018-09-30 was $56.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month |
|---|---|---|---|
| 2020-03-31 | $26.00K 10-Q · filed 2020-05-14 | $54.00K derived: sum of 2 quarters · filed 2020-05-14 | $92.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $28.00K 10-Q · filed 2020-02-13 | $84.00K 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $58.00K 10-Q · filed 2019-11-13 | ||
| 2018-09-30 | $56.00K 10-Q · filed 2019-11-13 |